🟢 100/100

This product looks safe

  • Folate: 167mg is 167.0× the Tolerable Upper Intake Level (1.0mg)
  • 54% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Folate: 167mg is 167.0× the Tolerable Upper Intake Level (1.0mg)

Label Data

20 Gram(s) Serving Size
45 Servings
Other Combinations Product Type
54% Evidence Coverage

Supplement Facts — Evidence Check

Calories
74 Calorie(s)
Total Fat
0.7 Gram(s) (1% DV)
Cholesterol
7 mg (2% DV)
Sodium
69 mg (3% DV)
Total Carbohydrates
10 Gram(s) (3% DV)
Protein
6.6 Gram(s) (13% DV)
Iron
1.3 mg (7% DV)
Vitamin A
1502 mcg RAE (167% DV)
Vitamin C
1 Gram(s) (1111% DV)
20 mcg (100% DV)
✅ 1.3× RDA — within safe limits 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.02mg UL 0.1mg
EVNolMax 15% powder
34 mg
10 mg (833% DV)
📊 8.3× RDA — above typical dose 📚 76 studies (Tier A: 0, B: 33)
RDA 1.2mg This product: 10mg
10 mg (769% DV)
📊 7.7× RDA — above typical dose 📚 12 studies (Tier A: 0, B: 1)
RDA 1.3mg This product: 10mg
25 mg NE (156% DV)
✅ 1.8× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 25mg UL 35mg
10 mg (588% DV)
📊 7.7× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 10mg UL 100mg
167 mcg DFE (42% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 167.0× (UL: 1.0 mg) 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 167mg UL 1.0mg
200 mcg (8333% DV)
📊 83.3× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.2mg
100 mcg (333% DV)
📊 3.3× RDA — above typical dose 📚 26 studies (Tier A: 0, B: 11)
RDA 0.03mg This product: 0.1mg
25 mg (500% DV)
📊 5.0× RDA — above typical dose 📚 1 studies — no high-quality reviews
RDA 5mg This product: 25mg
Calcium
135 mg (10% DV)
50 mcg (33% DV)
✅ Within RDA (0.3× RDA of 0.15 mg) 📚 243 studies (Tier A: 4, B: 133)
RDA 0.15mg This product: 0.05mg UL 1.1mg
150 mg (36% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 150mg
15 mg (136% DV)
✅ 1.4× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 15mg UL 40mg
100 mcg (182% DV)
✅ 1.8× RDA — within safe limits 📚 172 studies (Tier A: 0, B: 67)
RDA 0.055mg This product: 0.1mg UL 0.4mg
1 mg (111% DV)
✅ 1.1× RDA — within safe limits 📚 36 studies (Tier A: 0, B: 11)
RDA 0.9mg This product: 1mg UL 10mg
2 mg (87% DV)
✅ Within RDA (0.9× RDA of 2.3 mg) 📚 8 studies — no high-quality reviews
RDA 2.3mg This product: 2mg UL 11mg
50 mcg (143% DV)
✅ 1.4× RDA — within safe limits 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.05mg
100 mcg (222% DV)
✅ 2.2× RDA — within safe limits 📚 2 studies — no high-quality reviews
RDA 0.045mg This product: 0.1mg UL 2mg
Potassium
100 mg (2% DV)
📊 Market median: 600.0mg (7 products) 📚 39 studies (Tier A: 2, B: 13)
This product: 250mg
4 mg
📊 Market median: 10.0mg (35 products) 📚 5 studies (Tier A: 0, B: 2)
This product: 4mg
250 mg
📊 Market median: 500.0mg (861 products) 📚 60 studies (Tier A: 4, B: 13)
This product: 250mg
125 mg
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 125mg
📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 250mg
📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)
This product: 250mg
100 mg
📊 Market median: 30.0mg (12 products) 📚 5 studies — no high-quality reviews
This product: 100mg
📊 Market median: 260.0mg (249 products) 📚 156 studies (Tier A: 4, B: 61)
This product: 200mg
MaitakeGold 404
150 mg
200 mg
📊 Market median: 200.0mg (136 products) 📚 3 studies — no high-quality reviews
This product: 200mg
📊 Market median: 450.0mg (254 products) 📚 240 studies (Tier A: 0, B: 100)
This product: 500mg
📊 Market median: 450.0mg (390 products) 📚 155 studies (Tier A: 0, B: 63)
This product: 250mg
📊 Market median: 470.0mg (230 products) 📚 9 studies (Tier A: 3, B: 3)
This product: 250mg
📊 Market median: 200.0mg (198 products) 📚 6 studies — no high-quality reviews
This product: 100mg

Other Ingredients

Psyllium Whey Protein concentrate Oat Bran Xylitol Rice Bran Apple Fiber Soy Protein concentrate Silicon Dioxide

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (96% of products) Structure/Function (81% of products) Nutrient (19% of products) No Claim (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use As a dietary supplement, 1 level scoop one or two times daily, mixed with desired liquid, or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

Contains: Soy.

Warning: Consuming this product can expose you to lead which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov/food

🧪 Formulation Notes

Originally formulated by Dr. Friedrich Douwes, MD (Klinik St. Georg) and Stephen A. Levine, PhD (ARG), this reformulated blend includes riboflavin-5-phosphate, P5P, 5-MTHF, methylcobalamin, SelenoExcell selenium complex, and MaitakeGold 404 mushroom blend. Powder form is convenient and cost-effective.

Variations in product color may occur.

Total immune nutrient support

Additional Information

Keep in a cool, dry place, tightly capped.

Product is sold by weight, not volume. Some settling may occur.

Nutricology Innovative Nutrition

Product Details

UPC / SKU 7 13947 53820 7
DSLD Entry Date 2020-09-25
Product Type Other Combinations
Form Powder
Brand NutriCology
DSLD ID 236897
Data Updated 2026-04-11

Research Evidence

41 Research Sources
51 Avg Quality Score
19 Rct
13 Meta Analysis
9 Clinical Trial
B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Meta Analysis The Cochrane database of systematic reviews 2019
B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
Rct Nature communications 2024
B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Meta Analysis The Cochrane database of systematic reviews 2020
B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015
B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Rct BMC medicine 2019
B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024
B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
Meta Analysis The Cochrane database of systematic reviews 2006
B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Bipolar disorders 2021
B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Meta Analysis Psychopharmacology 2020
B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Meta Analysis Archivos de bronconeumologia 2024
View all evidence for Nac →

Compare Similar Products

View all Nac products →